FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2019

Top Holdings104 positions

Checking export access…
Activity:
AABAAABADelisted
Fund

ALTABA INC

28.4M$2B12.8%——
3 qtrssince 2018-Q4
Increased
64
CELGCELGDelisted

CELGENE CORP

15.4M$1.4B9.3%——
2 qtrssince 2019-Q1
Increased
96
SPYSPY
PUT

SPDR S&P 500 ETF TR

3.6M$1.1B7.0%———
Increased
—
RHTRHTDelisted

RED HAT INC

5.1M$963.7M6.3%——
3 qtrssince 2018-Q4
Increased
87
APCAPCDelisted

ANADARKO PETE CORP

10.5M$738.4M4.8%——
1 qtr
New
88
WCGWCGDelisted

WELLCARE HEALTH PLANS INC

2.2M$634.3M4.1%——
2 qtrssince 2019-Q1
Increased
93

WABTEC

6.6M$471.3M3.1%$67.57+1.80%
3 qtrssince 2018-Q4
Increased
61

IQVIA HLDGS INC

2.6M$415M2.7%$121.59+32.33%
3 qtrssince 2018-Q4
Increased
63
8.5M$393.8M2.6%——
3 qtrssince 2018-Q4
Increased
75

FIDELITY NATL INFORMATION SV

2.8M$348.7M2.3%$94.21+14.80%
3 qtrssince 2018-Q4
Increased
68

ELEVANCE HEALTH INC

1.1M$296.3M1.9%$240.95+7.34%
3 qtrssince 2018-Q4
Increased
60

CHARTER COMMUNICATIONS INC N

700,405$276.8M1.8%$285.08+38.62%
3 qtrssince 2018-Q4
Decreased
0

GENERAL DYNAMICS CORP

1.3M$242.8M1.6%$135.91+14.43%
3 qtrssince 2018-Q4
Increased
59
PLYAPLYADelisted

PLAYA HOTELS & RESORTS NV

30.6M$236M1.5%——
3 qtrssince 2018-Q4
Unchanged
0
3.6M$229.7M1.5%——
3 qtrssince 2018-Q4
Decreased
0

SHERWIN WILLIAMS CO

465,699$213.4M1.4%$135.82+5.45%
2 qtrssince 2019-Q1
Increased
58

VISA INC

1.2M$206.1M1.3%$124.91+31.97%
3 qtrssince 2018-Q4
Decreased
0

EQUIFAX INC

1.5M$198M1.3%$87.63+46.63%
3 qtrssince 2018-Q4
Decreased
0
EQIXEQIX
REIT

EQUINIX INC

383,132$193.2M1.3%$309.48+44.48%
3 qtrssince 2018-Q4
Decreased
0

S&P GLOBAL INC

840,786$191.5M1.2%$186.89+8.48%
2 qtrssince 2019-Q1
Decreased
0
$15.4B
AUM
104
Positions
Q2 2019
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+6%Q1'19$12.1B+18%Q2'19$14.3B
Activity profile
$ moved · Q2'19
New22%Increased47%Decreased19%Exited12%
Composition
Equity vs derivatives
Equity93%Puts7%Calls0%
Holding period
Avg 1.5 quarters
<1Q18%1-4Q82%1-2Y0%2Y+0%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $15.4B across 104 positions as of Q2 2019. Top holdings: AABA (12.8%), CELG (9.3%), SPY puts (7.0%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q2 2019 Summary

Active quarter - 19 new positions, 9 exits, 34 increased. Top move: CELG (INCREASED, conviction 96). Portfolio: $15.4B across 104 positions.

Top holdings by portfolio weight

Total AUM$14B
AABA12.80%
CELG9.29%
RHT6.27%
APC4.80%
WCG4.13%
WAB3.07%
IQV2.70%
AR22.56%
FIS2.27%
ELV1.93%
Other1.80%

Portfolio allocation by GICS sector

Sectors10
Unknown53.14%
Healthcare16.33%
Industrials6.41%
Energy5.20%
Communication Services5.00%
Technology4.43%
Financial Services3.73%
Consumer Cyclical2.67%
Real Estate1.59%
Basic Materials1.50%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L48
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used